79G-29512-55225 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-27
Dose 1 — Moderna
2022-06-29
Registered in v-safe
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-04
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-13
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-20
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-29
Dose 2 — Moderna
2022-09-10
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-28
Survey response — 3 months, dose 2, under 3
MedDRA: Cough, Respiratory syncytial virus infection, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, wheezy breathing-was diagnosed as RSV

MedDRA releases: 2024-11 · check-in free text available
2023-01-27
Health check-in — 6 months, dose 2, under 3
Feeling: Fair

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-27	Moderna	No
2	2022-07-29	Moderna	No

Free text

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-28

Symptoms: Cough, wheezy breathing-was diagnosed as RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Wheezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release